GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: CBPD409 | compound 25 [PMID: 38530938]
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: CBPD-409 is an orally bioactive PROTAC degrader that targets the CBP (CREB binding protein) and p300 (E1A binding protein p300) proteins [1]. It binds to the target proteins using a GNE-049-derived moiety, and a thalidomide ligand is used to interact with the cereblon E3 ubiquitin ligase.   CBP and p300 are bromodomain and histone acetyltransferase (HAT) domain-containing proteins that act as androgen receptor transcriptional coactivators. CBPD-409 was designed to disrupt CBP/p300-induced androgen receptor expression in prostate cancers. | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| Ligand families/groups | PROTACs, molecular glues and other degraders | 
| Synonyms  | 
| CBPD409 | compound 25 [PMID: 38530938] | 
| Database Links  | |
| GtoPdb PubChem SID | 496703271 | 
| PubChem CID | 171364440 | 
| Search Google for chemical match using the InChIKey | CXJGNQXWKVPWMM-KEQSSBIPSA-N | 
| Search Google for chemicals with the same backbone | CXJGNQXWKVPWMM | 
| UniChem Compound Search for chemical match using the InChIKey | CXJGNQXWKVPWMM-KEQSSBIPSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | CXJGNQXWKVPWMM-KEQSSBIPSA-N |